loading...| Preferred Name |
Tenecteplase |
|
| Synonyms |
|
|
| Definitions |
A 527 amino acid glycoprotein and the modified form of the naturally occurring human plasminogen activator (tPA) with tissue plasminogen activating activity. Tenecteplase (TNKase) is a serine protease created by introducing substitutions of threonine 103 with asparagine, asparagine 117 with glutamine within the kringle 1 domain, and a tetra-alanine substitution at amino acids 296-299 in the protease domain. TNKase converts fibrin-bound plasminogen to plasmin by cleaving the Arg/Val bond in plasminogen. Plasmin in turn degrades the fibrin matrix of the thrombus mass, thereby helps eliminate blood clots or arterial blockages that cause myocardial infarction. |
|
| ID |
http://purl.obolibrary.org/obo/NCIT_C29489 |
|
| CAS_Registry |
191588-94-0 |
|
| code |
C29489 |
|
| Contributing_Source |
FDA |
|
| definition |
A 527 amino acid glycoprotein and the modified form of the naturally occurring human plasminogen activator (tPA) with tissue plasminogen activating activity. Tenecteplase (TNKase) is a serine protease created by introducing substitutions of threonine 103 with asparagine, asparagine 117 with glutamine within the kringle 1 domain, and a tetra-alanine substitution at amino acids 296-299 in the protease domain. TNKase converts fibrin-bound plasminogen to plasmin by cleaving the Arg/Val bond in plasminogen. Plasmin in turn degrades the fibrin matrix of the thrombus mass, thereby helps eliminate blood clots or arterial blockages that cause myocardial infarction. |
|
| FDA_UNII_Code |
WGD229O42W |
|
| in_subset |
http://purl.obolibrary.org/obo/NCIT_C63923 |
|
| label |
Tenecteplase |
|
| Legacy Concept Name |
Tenecteplase |
|
| Preferred_Name |
Tenecteplase |
|
| prefixIRI |
NCIT:C29489 |
|
| prefLabel |
Tenecteplase |
|
| Semantic_Type |
Amino Acid, Peptide, or Protein Pharmacologic Substance |
|
| UMLS_CUI |
C0872913 |
|
| subClassOf |